AMANDA BROWN: Open Payments
NPI 1275913360 · LEESVILLE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,056 in 55 payments from 15 companies in 2025. Trend: 2023 $556 · 2024 $563 · 2025 $1,056
Food & beverage: $1,056
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 9 | $173 |
| Amgen Inc. | 12 | $166 |
| Corcept Therapeutics | 6 | $160 |
| Insulet Corporation | 7 | $160 |
| Tandem Diabetes Care, Inc. | 4 | $66 |
| ABBVIE INC. | 3 | $55 |
| Medtronic, Inc. | 2 | $55 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $49 |
| Forte Bio-Pharma LLC | 2 | $36 |
| Dexcom, Inc. | 2 | $31 |
Products named: Korlym, Omnipod, MOUNJARO, EVENITY, t:slim X2 Insulin Pump with Control-IQ, MINIMED 780G, OTEZLA, Kerendia.
Industry payments across LA — which companies pay providers there.
